Shankar Gopi

Shankar Gopi is listed in filings as Chief Development Officer at Larimar Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jan 27, 2026, including 4 public disclosures. Recent filings connect the profile to Larimar Therapeutics, Inc. (LRMR). The current snapshot covers public activity from Jan 24, 2025 to Jan 27, 2026. Reported amounts are shown as $483.8K to $553.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.